Biological characterization of a beta-galactosidase expressing clone of Trypanosoma cruzi CL strain
AUTOR(ES)
Le-Senne, Ana, Muelas-Serrano, Susana, Fernández-Portillo, Carlos, Escario, José Antonio, Gómez-Barrio, Alicia
FONTE
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
2002-12
RESUMO
Clone CL B5 of Trypanosoma cruzi is a beta-galactosidase expressing organism that was genetically transfected to be used for in vitro pharmacological screening. Biological parameters were determined, evaluating growth kinetics of epimastigotes, metacyclogenesis, infectivity to mammalian cell lines, parasitemia kinetics in mice and sensibility to nifurtimox and benznidazole. Differences in relation to other strains and CL parental strain were found, the most important being the incapability to produce death to mice in spite of the high inoculum used. However, it possesses the required features to be used for in vitro drug screening. Data obtained demonstrate that heterogeneity of T. cruzi appears even among clones of the same strain, and that these differences found do not prevent the use of clone CL B5 for the purpose that was engineered.
Documentos Relacionados
- Vaccinia virus recombinants expressing an 11-kilodalton beta-galactosidase fusion protein incorporate active beta-galactosidase in virus particles.
- Characterization of psychrotrophic microorganisms producing beta-galactosidase activities.
- Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase.
- Purification and characterization of a thermotolerant beta-galactosidase from Thermomyces lanuginosus.
- beta-Galactosidase chimeras: primary structure of a lac repressor-beta-galactosidase protein.